Transgene

About:

Transgene is a biotechnology company that designs and develops innovative immunotherapies.

Website: http://www.transgene.fr

Twitter/X: TransgeneSA

Top Investors: Natixis

Description:

Transgene is an integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Their expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.

Total Funding Amount:

82.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Illkirch-graffenstaden, Alsace, France

Founded Date:

1979-01-01

Contact Email:

communication(AT)transgene.fr

Founders:

Pierre Chambon

Number of Employees:

501-1000

Last Funding Date:

2023-07-17

IPO Status:

Public

Industries:

© 2025 bioDAO.ai